Principal Financial Group Inc Pa Vmed Inc. Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.85 - $1.41 $11,340 - $18,812	-13,342 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$1.16 - $2.5 $10,690 - $23,040	-9,216 Reduced 40.85%	13,342 $18,000
Q4 2021 Feb 09, 2022	BUY	$2.46 - $8.74 $18,400 - $65,375	7,480 Added 49.61%	22,558 $56,000
Q3 2021 Nov 09, 2021	BUY	$5.1 - $9.39 $18,283 - $33,663	3,585 Added 31.19%	15,078 $129,000
Q2 2021 Aug 10, 2021	SELL	$3.95 - $6.88 $7,189 - $12,521	-1,820 Reduced 13.67%	11,493 $73,000

Q1 2021 May 10, 2021	BUY	$2.01 - $5.55 $26,759 - $73,887	13,313 New	13,313 $59,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $64.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.